法學期刊
  • 社群分享
論著名稱:
歐洲專利規範中之「公序良俗」條款檢驗標準:以人類胚胎幹細胞專利為例(Morality and Ordre Public Criteria in European Patent Law: Example of Stem Cells Patentability)
文獻引用
編著譯者: 許曉芬
出版日期: 2011.01
刊登出處: 台灣/中正財經法學第 2 期/53-89 頁
頁  數: 37 點閱次數: 1349
下載點數: 148 點 銷售明細: 權利金查詢 變更售價
授 權 者: 許曉芬
關 鍵 詞: 公序良俗可專利性胚胎幹細胞歐洲專利公約歐洲生物科技指令(98/44/EC)生物科技相關發明
中文摘要: 由於胚胎幹細胞具有產出不同細胞型態的潛力,許多專家相信透過人類胚胎幹細胞研究將可帶來醫療上的重大革命。但胚胎幹細胞相關之法律及倫理議題,卻始終引發熱烈的討論與爭議。歐洲專利公約(European Patent Convention)第 53 條 a 款規定發明之商業利用違反公共秩序與道德者,不予專利。然而公序良俗的概念太過抽象,為了確保所有歐盟會員國對於涉及生物科技的發明都能依照同樣標準有效保護,以維護法之安定性,歐洲生物科技指令(98/44/EC)指令試著將違反公序良俗之發明例示化,提供一參考準則。歐洲專利局上訴委員會與擴大上訴委員會,近年來亦試圖將公序良俗條款之檢驗標準具體化,並在其最新決定 G02/06 中,對人類胚胎幹細胞之可專利性進行深入的討論。本文認為公序良俗條款有存在之必要與價值,在維持法安定性的前提下,公序良俗條款及其例示規定雖為例外條款,但並非表示適用更嚴格或者更狹義的解釋方式,仍須考慮條文上下文及其目的而進行一般性的解釋。而歐洲專利規範中所累積之見解,將可提供解釋公序良俗條款上之借鏡與參考。
英文關鍵詞: MoralityOrdre PublicStem cellsEuropean Patent LawDirective 98/44/ECBiotechnological invention
英文摘要: Stem cell technology has the potential to bring the revolution to the way that certain diseases are treated. However, the use of embryos raises significant moral and ethical questions in many fields, including the patent system.
Article 53(a) of the European Patent Convention (the “EPC”) 2000 excludes “inventions the commercial exploitation of which would be contrary to “ordre public” or morality” from patentability. In addition, there is a specific exclusion to the use of human embryos for industrial or commercial purposes which has been developed according to the principles set by EC Directive 98/44/EC.
The Technical Board of Appeals (TBA) and Enlarged Board of Appeals (EBA) at the European Patent Office (EPO) have tried in several decisions to establish the concrete standards for examining the ordre public and morality criteria in patent law to ensure legal security in Europe. The most recent focus has been the WARF case (G 02/06) decided by EBA in November 2008.
This article attempts to analyze these recent decisions by considering the definition and the scope of the ordre public and morality criteria in the light of the ratio legis of Article 53 (a) EPC. By doing so, the application of these criteria in practice can be defined and the interpretation of those legal standards which is coherent and useful to the development of patent law can be introduced.
目  次: 壹、前言
貳、公序良俗條款與歐洲專利規範
一、公序良俗條款於專利法上之定義
二、公序良俗條款於歐洲專利規範中之現況
參、公序良俗條款與人類胚胎幹細胞
一、公序良俗條款於人類胚胎幹細胞專利之適用
二、G02/06 WARF 一案對於人類胚胎幹細胞可專利性之見解
肆、結論
相關法條:
相關判解:
相關函釋:
相關論著:
許曉芬,歐洲專利規範中之「公序良俗」條款檢驗標準:以人類胚胎幹細胞專利為例,中正財經法學,第2期,53-89頁,2011年01月。
返回功能列